NLM Digital Collections

Search

Start Over Subjects United States ✖Remove constraint Subjects: United States Publication Year 2019 ✖Remove constraint Publication Year: <span class="single" data-blrl-single="2019">2019</span>

63. Indian Health Service: facilities reported expanding services following increases in health insurance coverage and collections : report to Congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, September 2019
Subject(s):
Alaskan Natives
American Natives
Insurance Coverage -- legislation & jurisprudence
Medicaid -- legislation & jurisprudence
Insurance Coverage -- statistics & numerical data
United States
United States. Indian Health Service
United States.

64. Indian Health Service has strengthened patient protection policies but must fully integrate them into practice and organizational culture

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, December 2019
Subject(s):
American Natives
Alaskan Natives
Child Abuse, Sexual -- prevention & control
Patients
Sex Offenses -- prevention & control
United States
United States. Department of Health and Human Services
United States. Indian Health Service

65. Billions in estimated Medicare Advantage payments from chart reviews raise concerns

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, December 2019
Subject(s):
Insurance, Health, Reimbursement
Medical Records -- economics
Medicare Part C -- economics
Quality of Health Care
Risk Adjustment
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

67. Drug safety: preliminary findings indicate persistent challenges with FDA foreign inspections : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, December 10, 2019
Subject(s):
Drug Industry -- legislation & jurisprudence
Government Regulation
Pharmaceutical Preparations -- standards
United States
United States. Food and Drug Administration

68. Substance use disorder: prevalence of recovery homes, and selected states’ investigations and oversight : testimony before the Committee on Finance, United States Senate

Publication:
Washington, DC : United States Government Accountability Office, October 24, 2019
Subject(s):
Fraud -- legislation & jurisprudence
Government Regulation
Substance Abuse Treatment Centers -- legislation & jurisprudence
United States

69. Tribal programs: resource constraints and management weaknesses can limit federal program delivery to tribes : testimony before the Subcommittee for Indigenous Peoples of the United States, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, November 19, 2019
Subject(s):
American Natives -- legislation & jurisprudence
Government Regulation
Minority Health -- economics
Population Groups -- legislation & jurisprudence
United States

70. Generic drug development: stakeholders’ views of risk evaluation and mitigation strategies differ : report to the Chairman, Committee on Energy and Commerce, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, October 2019
Subject(s):
Drug Industry -- legislation & jurisprudence
Drugs, Generic -- isolation & purification
Government Regulation
Risk Evaluation and Mitigation -- legislation & jurisprudence
United States
United States. Food and Drug Administration